Phase I trial of hypoxia-responsive CEA CAR-T cell therapy in patients with heavily pretreated solid tumor via intraperitoneal or intravenous transfusion. Three-year disease-free survival after ...
Well, 2020 was something, wasn’t it? I’d love to tell you that Cannonball Read chugged along smoothly last year, unaffected by any issues related to the pandemic. But faintingviolet and I decided in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback